Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Certara

< Previous 1 2 Next >
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Second Quarter 2025 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
From Certara
Via GlobeNewswire
Tickers CERT
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
From Certara
Via GlobeNewswire
Tickers CERT
Certara Announces Expansion of Clinical Technology Collaboration with Merck
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports First Quarter 2025 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
From Certara
Via GlobeNewswire
Tickers CERT
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
From Certara
Via GlobeNewswire
Tickers CERT
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Fourth Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Showcases 2024 Research Wins With Over 100 Papers Published
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Third Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in the Stephens Annual Investment Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Appoints John Reynders as New Independent Board Member
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
From Certara
Via GlobeNewswire
Tickers CERT
Certara Completes Acquisition of Chemaxon
From Certara
Via GlobeNewswire
Tickers CERT
Certara’s Simcyp Consortium Celebrates 25th Anniversary
From Certara
Via GlobeNewswire
Tickers CERT
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Launches Phoenix™ Version 8.5 Drug Development Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Second Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
From Certara
Via GlobeNewswire
Tickers CERT
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.